Related Experiment Videos
Assessing depression in schizophrenia: the Calgary Depression Scale
D Addington1, J Addington, E Maticka-Tyndale
1Department of Psychiatry, University of Calgary, Alberta, Canada.
The British Journal of Psychiatry. Supplement
|December 1, 1993
Summary
A new Calgary Depression Scale effectively assesses depression in schizophrenia patients. This validated scale distinguishes depressive symptoms from negative and extrapyramidal symptoms in psychotic populations.
Area of Science:
- Psychiatry
- Clinical Psychology
- Psychopathology
Background:
- Existing depression scales are often unsuitable for psychotic populations, lacking items to differentiate depressed from non-depressed individuals with psychosis.
- This limitation necessitates the development of specialized assessment tools for conditions like schizophrenia.
Purpose of the Study:
- To introduce and validate the Calgary Depression Scale, specifically designed for assessing depression in individuals with schizophrenia.
- To ensure the scale accurately measures depressive symptoms without conflating them with other symptom clusters.
Main Methods:
- The Calgary Depression Scale was developed using factor analysis and reliability analysis from two established depression scales.
- The scale's reliability, congruence with self-report measures, and validity were assessed in an initial sample.
- Further testing in a second sample examined the scale's discriminant validity against negative and extrapyramidal symptoms.
Main Results:
- The Calgary Depression Scale demonstrated good reliability and validity in the initial sample.
- It showed congruence with a self-report depression scale.
- Crucially, the scale exhibited no overlap with negative or extrapyramidal symptoms in the second sample, confirming its specificity.
Conclusions:
- The Calgary Depression Scale is a reliable and valid instrument for assessing depression in schizophrenia.
- Its ability to differentiate depressive symptoms from other symptom domains makes it a valuable tool for clinical practice and research in psychotic disorders.